The mechanism of cholera toxin adjuvanticity

Research in Immunology

Volumn 148, Issue 8-9, 1997, Pages 504-520

  Lycke, N ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; CHOLERA TOXIN B SUBUNIT; CYTOKINE; ESCHERICHIA COLI ENTEROTOXIN; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN A; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 2;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; B LYMPHOCYTE DIFFERENTIATION; CYTOKINE RELEASE; GERMINAL CENTER; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TOXIN STRUCTURE;

EID: 0031255006     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(98)80144-2     Document Type: Article

References (114)

1. Ågren, L.C., Ekman, L., Löwenadler, L. & Lycke, N.Y. (1997), Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit. J. Immunol, 158, 3936-3946.
2. Anastassiou, E.D., Yamada, H., Francis, M.L., Mond, J.J. & Tsokos, G.C. (1990), Effects of cholera toxin on human B cells: cholera toxin induces B cell surface DR expression while it inhibits anti-μ antibody-induced cell proliferation. J. Immunol., 145, 2375-2380.
3. Anderson, D.L. & Tsoukas, C.D. (1989), Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway. J. Immunol., 143, 3647-3652.
4. Ban, E.M., van Ginkel, F.W., Simecka, J.W., Kiyono, H., Robinson, H.L. & McGhee, J.R. (1997), Mucosal immunization with DNA encoding influenza hemagglutinin. Vaccine, 15, 811-813.
5. Bergquist, C., Lagergård, T., Lindblad, M. & Holmgren, J. (1995), Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates. Infect. Immun., 63, 2021-2025.
6. Berstad, A.K., Holst, J., Mogster, B., Haugen, I.L. & Haneberg, B. (1997), A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin. Vaccine, 15, 1473-1478.
7. Blanchard, T.G., Lycke, N., Czinn, S.J. & Nedrud, J. (1997), Recombinant cholera B subunit is not an effective mucosal adjuvant for oral immunization of mice against H. felis. Immunology, in press.
8. Bourguin, I., Chardes, T. & Bout, D. (1995), Peritoneal macrophages from C57B1/6 mice orally immunized with Toxoplasma gondii antigens in association with cholera toxin possess an enhanced ability to inhibit parasite multiplication. FEMS Immunol. Med. Microbiol., 12, 121-126.
9. Bowen, J.C., Nair, S.K., Reddy, R. & Rouse, B.T. (1994), Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with nonreplicating antigens. Immunology, 81, 338-342.
10. Bromander, A.K., Ekman, L., Kopf, M., Nedrud, J. & Lycke, N. (1996), IL-6 deficient mice exhibit normal IgA responses to local immunizations and Helicobacter felis infection. J. Immunol., 156, 4290-4298.
11. Bromander, A.K., Holmgren, J. & Lycke, N. (1991), Cholera toxin stimulates IL-1 production and enhances antigen-presentation by macrophages in vitro. J. Immunol., 146, 2908-2929.
12. Bromander, A.K., Holmgren, J. & Lycke, N. (1993), Cholera toxin enhances alloantigen-presentation by cultured intestinal epithelial cells. Scand. J. Immunol., 37, 452-458.
13. Burnette, N., Mar, V.L., Platler, W., Schlotterbeck, D., McGinley, D., Stoney, S., Rhode, S.M.F. & Kaslow, H.R. (1991), Site-specific mutagenisis of the catalytic subunit of cholera toxin: substituting lysine for arginine 7 causes loss of activity. Infect. Immun., 59, 4266-4270.
14. Cassell, D.J. & Schwartz, R.H. (1994), A quantitative analysis of antigen-presenting cell function; activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing co-stimulation. J. Exp. Med., 180, 1829-1837.
15. Chen, K.-S. & Strober, W. (1990), Cholera holotoxin and its B subunit enhance Peyer's patch B-cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response. Eur. J. Immunol., 20, 433-436.
16. Clarke, C.J., Wilson, A.D., Williams, N.A. & Stokes, C.R. (1991), Mucosal priming of T-lymphocyte responses to fed protein antigens using cholera toxin as an adjuvant. Immunology, 72, 323-328.
17. Cong, Y., Weaver, C.T. & Elson, C.O. (1997), The mucosal adjuvanticity of cholera toxin involves enhancement of co-stimulatory activity by selective up-regulation of B-7.2 expression. J. Immunol., 159, 5301-5308.
18. + T cells to protein antigens in vivo. J. Immunol., 155, 3734-3739.
19. Cuatrecasas, P. (1973), Gangliosides and membrane receptors for cholera toxin. Biochemistry, 12, 3558-3566.
20. Czerkinsky, C., Russell, M.W., Lycke, N., Lindblad, M. & Holmgren, J. (1989), Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect. Immun., 57, 1072-1077.
21. Dallas, W.S. & Falkow, S. (1980), Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin. Nature, 288, 499-501.
22. Dickinson, B.L. & Clements, J.D. (1995), Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun., 63, 1617-1623.
23. Douce, G., Fontana, M., Pizza, M., Rappuoli, R. & Dougan, G. (1997), Intranasal immunogenicity and adjuvanticity of site-directed mutant derivates of cholera toxin. Infect. Immun., 65, 2821-2828.
24. Douce, G., Turcotte, C., Cropley, I., Roberts, M., Pizza, M., Domenghini, M., Rappuoli, R. & Dougan, G. (1995), Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as non-toxic, mucosal adjuvants. Proc. Natl. Acad. Sci. USA, 92, 1644-1648.
25. Elson, C.O. & Ealding, W. (1984a), Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol., 132, 2736-2741.
26. Elson, C.O. & Ealding, W. (1984b), Cholera toxin feeding did not induce oral tolerance and abrogated oral tolerance to an unrelated protein antigen. J. Immunol., 133, 2892-2897.
27. + T cell subset by cholera toxin (CT) and its B-subunit (CT-B). Faseb, J., 4, A1864.
28. Elson, C.O., Holland, S.P., Dertzbaugh, M.T., Cuff, C.F. & Anderson, A.O. (1995), Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit. J. Immunol., 154, 1032-1039.
29. Etchart, N., Buckland, R., Liu, M.A., Wild, T.F. & Kaiserlian, D. (1997), Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measels virus haemagglutinin. J. Gen. Virol., 78, 1577-1580.
30. Francis, M.L., Okazaki, I., Moss, J., Kurosky, A., Pecanha, L.M. & Mond, J.J. (1995), cAMP-independent effects of cholera toxin on B cell activation. III. Cholera toxin A subunit-mediated ADP-ribosylation acts synergistically with ionomycin or IL-4 to induce B cell proliferation. J. Immunol., 154, 4956-4964.
31. Francis, M.L., Ryan, J., Jobling, M.G., Holmes, R.K., Moss, J. & Mond, J. (1992), Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation. J. Immunol., 148, 1999-2005.
32. Frey, A., Giannasca, K.T., Weltzin, R., Giannasca, P.J., Reggio, H., Lencer, W.I. & Neutra, M.R. (1996), Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J. Exp. Med., 184, 1045-1059.
33. Gause, W.C., Chen, S.J., Greenwald, R.J., Halvorson, M.J., Lu, P., Zhou, X.d., Morris, S.C., Lee, K.P., June, C.H., Finkelman, F.D., Urban, J.F. & Abe, R. (1997a), CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. J. Immunol., 158, 4082.
34. Gause, W.C., Halvorson, M.J., Lu, P., Greenwald, R., Linsley, P., Urban, J.F. & Finkelman, F.D. (1997b), The function of costimulatory molecules and the development of IL-4-producing T cells. Immunol. Today, 18, 115.
35. Grant, C.C.R., Messer, R.J. & Cieplak, W. (1994), Role of trypsin-like cleavage at arginine 192 in the enzymatic and cytotonic activities of Escherichia coli heat-labile enterotoxin. Infect. Immun., 62, 4270-4278.
36. Gray, D., Dullforce, P. & Jainandinsing, S. (1994), Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction. J. Exp. Med., 180, 141-155.
37. + T cells in the normal gut mucosa. J. Immunol., 160, 754-763.
38. Haack, B.M., Emmrich, F. & Resch, K. (1993), Cholera toxin inhibits T cell receptor signalling by covalent modification of the CD3-ζ subunit. J. Immunol., 150, 2599-2606.
39. De Haan, L., Verweij, W.R., Feil, I.K., Lijnema, T.H., Hol, W.G.J., Agsterribbe, E. & Wilschut, J. (1996), Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin. Infect. Immun., 64, 5413-5416.
40. Haas, S., Miura-Fraboni, J., Zavala, F., Murata, K., Leone-Bay, A. & Santiago, N. (1996), Oral immunization with a model protein entrapped in microspheres prepared from derivatized alpha-ammo acids. Vaccine, 14, 785-791.
41. Hajishengallis, G., Hollingshead, S.K., Koga, T. & Russell, M.W. (1994), Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B Subunits. J. Immunol., 154, 4322-4332.
42. + T cells through IL-12 produced by Listeria-induced macrophages. Science, 260, 547-549.
43. Hörnqvist, E. & Lycke, N. (1993), Cholera toxin adjuvant strongly promotes T cell priming. Eur. J. Immunol., 23, 2136-2143.
44. Hörnquist, E., Ekman, L., Grdic, D., Schön, K. & Lycke, N. (1995), Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiation. J. Immunol., 155, 2877-2885.
45. Hörnquist, E., Grdic, D., Mak, T. & Lycke, N. (1996), CD8-deficient mice exhibit augmented mucosal immune responses and intact adjuvant effect of cholera toxin. Immunology, 87, 220-228.
46. Imboden, J.B., Shoback, D.M., Pattison, G. & Stobo, J.D. (1986), Cholera toxin inhibits the T-cell antigen receptor-mediated increases in inositol trisphospate and cytoplasmic free calcium. Proc. Natl. Acad. Sci. USA, 83, 5673-5677.
47. Jackson, R.J., Fujihashi, K., Xu-Amano, J., Kiyono, H., Elson, C.O. & McGhee, J.R. (1993), Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect. Immun., 61, 4272-4279.
48. Kjerrulf, M., Grdic, D., Ekman, L., Schön, K. & Lycke, N. (1997), Interferon-γ receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance. Immunology, 92, 60-68.
49. Kopf, M., Le Gros, G., Bachmann, M., Lamers, M.C., Bluethmann, H. & Köhler, G. (1993), Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature, 362, 245-248.
50. Kuklin, N., Daheshia, M., Karem, E., Manickan, E. & Rouse, B.T. (1997), Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol., 71, 3138-3145.
51. + T cells while decreasing IL-2 release and NF-AT induction. Int. Immunol., 9, 1333-1340.
52. Lane, P., Burdet, C., Hubele, S., Schedegger, D., Muller, U., McConell, F. & Kosco-Vilbois, M. (1994), B cell function in mice transgenic for mCTLA4-Hgl: lack of germinal centers correlated with poor affinity maturation and class switching despite normal priming of CD4+ T cells. J. Exp. Med., 179, 819-826.
53. Levine, M.M., Kaper, J.B., Black, R.E. & Clemens, M.L. (1983), New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol. Rev., 47, 510.
54. Li, T.-K. & Fox, B.S. (1996), Cholera toxin B subunit binding to an antigen-presenting cell directly co-stimulates cytokine production from a T cell clone. Int. Immunol., 8, 1849-1856.
55. Liang, X., Lamm, M.E. & Nedrud, J.G. (1988), Oral administration of cholera toxin Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. J. Immunol., 141, 1495-1501.
56. Liang, X., Lamm, M.E. & Nedrud, J.G. (1989), Cholera toxin as a mucosal adjuvant: glutaraldehyde-treatment dissociates adjuvanticity from toxicity. J. Immunol., 143, 484-490.
57. 2: separation of affinity from specificity. Mol. Immunol., 14, 1279-1285.
58. Löwenadler, B. & Lycke, N. (1994), Fusion proteins with heterologous T helper epitopes. Recombinant E. coli heat-stable enterotoxin proteins. Int. Rev. Immunol., 11, 103-111.
59. Lycke, N. (1993), Cholera toxin promotes B cell isotype switching by two different mechanisms: cAMP-induction augments germline Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation. J. Immunol., 150, 4810-4821.
60. Lycke, N. (1996), A molecular approach to the construction of an effective mucosal vaccine adjuvant: studies based on cholera toxin ADP-ribosylation and cell targeting, in "Essentials of mucosal immunology" (M.F. Kagnoff and H. Kiyono) (p. 563). Academic press, San Diego.
61. Lycke, N. & Holmgren, J. (1986), Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology, 59, 301-308.
62. Lycke, N. & Holmgren, J. (1987), Long-term cholera antitoxin memory in the gut can be triggered to antibody formation associated with protection within hours after an oral challenge immunization. Scand. J. Immunol., 25, 407-412.
63. Lycke, N. & Strober, W. (1989), Cholera toxin promotes B cell isotype differentiation. J. Immunol., 142, 3781-3787.
64. Lycke, N. & Holmgren, J. (1989), Adoptive transfer of gut mucosal antitoxin memory by isolated B cells one year after oral immunization with cholera toxin. Infect. Immun., 57, 1137-1141.
65. Lycke, N., Bromander, A.K., Ekman, L., Karlsson, U. & Holmgren, J. (1989), Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo. J. Immunol., 142, 20-27.
66. Lycke, N. & Svennerholm, A.-M. (1990), Presentation of immunogens at the gut and other mucosal surfaces, in "The Molecular Approach To New And Improved Vaccines" (Woodrow, M. Levine) (pp. 207-227). Marcel Dekker Inc., NY.
67. Lycke, N., Severinson, E. & Strober, W. (1991a), Molecular effects of cholera toxin on isotype differentiation. Immunol. Res., 10, 407-412.
68. Lycke, N., Severinson, E. & Strober, W. (1991b), Cholera toxin acts synergistically with IL-4 to promote IgG1 switch differentiation. J. Immunol., 145, 3316-3324.
69. Lycke, N., Karlsson, U., Sjölander, A. & Magnusson, K.-E. (1991c), The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand. J. Immunol., 33, 691-698.
70. Lycke, N., Tsuji, T. & Holmgren, J. (1992), The adjuvant effect of Vibrio cholerae and E. coli heat labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol., 22, 2277-2281.
71. Magagnoli, C., Manetti, R., Fontana, M.R., Gianelli, V., Giuliani, M.M., Rappuoli, R. & Pizza, M. (1996), Mutations in the A subunit affect yield, stability, and protease sensitivity of nontoxic derivates of heat-labile enterotoxin. Infect. Immun., 64, 5434-5438.
72. Marinaro, M., Boyaka, P.N., Finkelman, F.D., Kiyono, H., Jackson, R.J., Jirillo, E. & McGhee, J.R. (1997), Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J. Exp. Med., 3, 415-427.
73. Marinaro, M., Staats, H.F., Hiroi, T., Jackson, R.J., Coste, M., Boyaka, P.N., Okahashi, N., Yamamoto, M., Kiyono, H., Bluethmann, H., Fujihashi, K. & McGhee, J.R. (1995), Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol., 155, 4621-4629.
74. Matousek, M.P., Nedrud, J.G. & Harding, C.V. (1996), Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages. J. Immunol., 156, 4137-4145.
75. McGee, D.W., Elson, C.O. & McGhee, J.R. (1993), Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines. Infect. Immun., 61, 4637-4644.
76. M1 pentasaccharide. Prot. Sci., 3, 166.
77. Michetti, P., Kreiss, C., Kotloff, K., Porta, N., Blanco, J.L., Bachman, D., Sadlinger, P.F., Corthesy-Theulaz, I., Losonsky, G., Nichols, R., Stolte, M., Monath, T., Ackerman, S. & Blum (1997), Oral immunization of H. pylori infected adults with recombinant urease and LT adjuvant (Abstract). Gastroenterology, 112:A1042.
78. Mowat, A. (1994), Oral tolerance and Regulation of Immunity to dietary antigens, in "Handbook of Mucosal Immunology" (P. Ogra, J. Metscky, M. Lamm, W. Strober, J. McGhee, and J. Bienenstock) (pp. 185-202). Academic Press, San Diego.
79. Mowat, A.M., Maloy, K.J. & Donachie, A.M. (1993), Immune-stimulating complexes as adjuvants for local and systemic immunity after oral immunization with protein antigens. Immunology, 80, 527-534.
80. Munoz, E., Zubiaga, A.M., Merrow, M., Sauter, N.P. & Huber, B. (1990), Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J. Exp. Med., 172, 95-103.
81. Nashar, T.O., Webb, H.M., Eaglestone, S., Williams, N.A. & Hirst, T.R. (1996a), Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets. Immunology, 93, 226-230.
82. + T cells. Int. Immunology, 8, 731-736.
83. Nedrud, J.G. & Sigmund, N. (1990), Cholera toxin as a mucosal adjuvant: III. Antibody responses to nontarget dietary antigens are not increased. Reg. Immunol., 3, 217-222.
84. + Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect. Immun., 64, 1516-1525.
85. Papadimitriou, E., Mintzas, A., Skoutari, M., Dimitracopoulos, G. & Anastassiou, E.D. (1997), Cholera toxin stimulates human B-cell DR antigen biosynthesis at the level of translation. Cell. Immunol., 180, 176-184.
86. Rappuoli, R. & Pizza, M. (1991), Structure and evolutionary aspects of ADP-ribosylating toxins, in "Sourcebook of bacterial protein toxins" (J.E. Alouf and J.H. Freer) (pp. 1-21). Academic Press, London.
87. Ronchese, F., Hausmann, B., Hubele, S. & Lane, P. (1994), Mice transgenic for a soluble form of murine CTLA4 show enhanced expansion of antigen-specific CD4+ T-cells and defective antibody production in vivo. J. Exp. Med., 179, 809-816.
88. Russel, M.W. & Wu, H.-Y. (1991), Distribution, persistence and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit. Infect. Immun., 59, 4061-4070.
89. h cells in mesenteric lymph nodes after oral immunization with protein antigen and cholera toxin. Int. Immunol., 9, 1555-1562.
90. Sixma, T.K., Kalk, K.H., van Zanten, B.A., Dauter, Z., Kingma, J., Witholt, B. & Hol, W.G. (1993), Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin. J. Mol. Biol., 230, 890.
91. Smith, E., Donachie, A.M., McLaren, F.H. & Mowat, A. (1998), Preservation of mucosal and systemic adjuvant properties of Iscoms in the absence of functional interleukin 4 or interferon gamma. Immunology (in press).
92. Snider, D.P., Marshall, J.S., Perdue, M.H. & Liang, H. (1994), Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein ag and cholera toxin. J. Immunol., 153, 647-657.
93. Spangler, B.D. (1992), Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev., 56, 622-630.
94. Stack, R.M., Lenschow, D.J., Gray, G.S., Bluestone, J.A. & Fitch, F.W. (1994), IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. J. Immunol., 152, 5723-5730.
95. Stavnezer, J., Radcliff, G., Lin, Y.-C., Nietupski, J., Berggren, L., Sitia, R. & Severinson, E. (1988), Immunoglobulin heavy-chain switching may be directed by prior induction of transcripts from constant region genes. Proc. Natl. Acad. Sci. USA, 85, 7704-7708.
96. Stockinger, B., Zal, T., Zal, A. & Gray, D. (1996), B cells solicit their own help from T cells. J. Exp. Med., 183, 891-901.
97. Strober, W. & Ehrhardt, R.O. (1994), Regulation of IgA B cell development, in "Handbook of Mucosal Immunology" (P.L. Ogra, W. Strober, J. Mestecky, J.R. McGhee, M.E. Lamm, and J. Bienenstock) (pp. 159-176). Academic Press, Inc., San Diego.
98. Sun, J.-B., Holmgren, J. & Czerkinsky, C. (1994), Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA, 91, 10795-10799.
99. Tamura, S., Miyata, K., Matsuo, K., Asanuma, H., Takahashi, H., Nakajima, K., Suzuki, Y., Aizawa, C. & Kurata, T. (1996), Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein. J. Immunol., 156, 3892-3900.
100. Tamura, S., Samegai, Y., Kurata, H., Nagamine, T., Aizawa, C. & Kurata, T. (1988), Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine, 6, 409-413.
101. Takahashi, I., Marinaro, M., Kiyono, H., Jackson, R.J., Nakagawa, I., Fujihashi, K., Hamada, S., Clements, J.D., Bost, K.L. & McGhee, J.R. (1996), Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J. Infect. Dis., 173, 627-635.
102. Tomasi, M., Dertzbaugh, M.T., Hearn, T., Hunter, R.L. & Elson, C.O. (1997), Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization. Eur. J. Immunol., 27, 2720-2725.
103. VanCott, J.L., Staats, H.F., Pascual, D.W., Roberts, M., Chatfield, S.N., Yamamoto, M., Coste, M., Carter, P.B., Kiyono, H. & McGhee, J.R. (1996), Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J. Immunol., 156, 1504-1514.
104. Van der Heijden, P.J., Bianchi, A.T., Dol, M., Pals, J.W., Stok, W. & Bokhout, B.A. (1991), Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B-subunit in mice. Immunology, 72, 89-93.
105. Vajdy, M. & Lycke, N. (1992), Cholera toxin adjuvant promotes longterm immunological memory in the gut mucosa to unrelated immunogens after oral immunization. Immunology, 75, 488-492.
106. Vajdy, M. & Lycke, N. (1993), Stimulation of antigen-specific T and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant. Immunology, 80, 197-203.
107. Vajdy, M. & Lycke, N. (1995), Mucosal memory B cells retain the ability to produce IgM antibodies even 2 years after oral immunizations. Immunology (in press).
108. Vajdy, M., Kosco-Vilbois, M., Kopf, M., Köhler, G. & Lycke, N. (1995), Impaired mucosal immune responses in IL-4 targeted mice. J. Exp. Med., 181, 41-53.
109. Wilson, A.D., Bailey, M., Williams, N.A. & Stokes, C.R. (1991), The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant. Eur. J. Immunol., 21, 2333-2340.
110. Woogen, S.D., Ealding, W. & Elson, C.O. (1987), Inhibition of murine lymphocyte proliferation by the B subunit of cholera toxin. J. Immunol., 139, 3764-3770.
111. Wu, H.-Y. & Russell, M.W. (1993), Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun., 61, 314-320.
112. Yamamoto, S., Kiyono, H., Yamamoto, M., Imaoka, K., Yamamoto, M., Fujihashi, K., Van Ginkel, F.W., Noda, M., Takeda, Y. & McGhee, J.R. (1997b), A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. USA, 94, 5267-5272.
113. Yamamoto, S., Takeda, Y., Yamamoto, M., Kurazono, H., Imaoka, K., Yamamoto, M., Fujihashi, K., Noda, M., Kiyono, H. & McGhee, J.R. (1997a), Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarreheagenicity but retain adjuvanticity. J. Exp. Med., 7, 1203-1210.
114. Xu-Amano, J., Kiyono, H., Jackson, R.J., Staats, H.F., Fujihashi, K., Burrows, P.D., Elson, CO., Pillai, S. & McGhee, J.R. (1993), Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa-associated tissues. J. Exp. Med., 178, 1309-1320.